Generex Biotechnology Corp Price Prediction
| GNBTDelisted Stock | USD 0.0001 0.00 0.00% |
Oversold Vs Overbought
41
Oversold | Overbought |
Generex Biotechnology stock price prediction is an act of determining the future value of Generex Biotechnology shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Generex Biotechnology's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Generex Biotechnology and does not consider all of the tangible or intangible factors available from Generex Biotechnology's fundamental data. We analyze noise-free headlines and recent hype associated with Generex Biotechnology Corp, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Generex Biotechnology based on different types of headlines from major news networks to social media. The Generex stock price prediction module provides an analysis of price elasticity to changes in media outlook on Generex Biotechnology over a specific investment horizon. Using Generex Biotechnology hype-based prediction, you can estimate the value of Generex Biotechnology Corp from the perspective of Generex Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Generex Biotechnology. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Generex Biotechnology to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Generex because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Generex Biotechnology after-hype prediction price | USD 1.25E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Generex |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Generex Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Generex Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Generex Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Generex Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Generex Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Generex Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Generex Biotechnology's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Generex Biotechnology's historical news coverage. Generex Biotechnology's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Generex Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Generex Biotechnology is very steady at this time. Analysis and calculation of next after-hype price of Generex Biotechnology is based on 3 months time horizon.
Generex Biotechnology OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Generex Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Generex Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Generex Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 4 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 25.00 |
|
Generex Biotechnology Hype Timeline
Generex Biotechnology is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Generex is forecasted to increase in value after the next headline, with the price projected to jump to 1.25E-4 or above. The average volatility of media hype impact on the company the price is insignificant. The price appreciation on the next news is projected to be 25.0%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Generex Biotechnology is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company currently holds 499.66 K in liabilities. Generex Biotechnology has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Generex Biotechnology until it has trouble settling it off, either with new capital or with free cash flow. So, Generex Biotechnology's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Generex Biotechnology sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Generex to invest in growth at high rates of return. When we think about Generex Biotechnology's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.Generex Biotechnology Related Hype Analysis
Having access to credible news sources related to Generex Biotechnology's direct competition is more important than ever and may enhance your ability to predict Generex Biotechnology's future price movements. Getting to know how Generex Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Generex Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GDEV | GDEV Inc | 0.1 | 2 per month | 0.00 | (0.05) | 3.62 | (3.08) | 9.30 | |
| BNTX | BioNTech SE | 2.44 | 10 per month | 0.00 | (0.16) | 2.21 | (2.17) | 9.89 | |
| EA | Electronic Arts | 0.1 | 11 per month | 0.00 | (0.19) | 1.31 | (1.82) | 5.17 | |
| GME | GameStop Corp | (0.75) | 9 per month | 0.00 | (0.12) | 4.09 | (5.92) | 30.45 | |
| ALVO | Alvotech | (0.05) | 9 per month | 3.04 | 0.02 | 4.10 | (5.67) | 26.48 | |
| EVVTY | Evolution Gaming Group | 0.00 | 0 per month | 2.13 | 0 | 3.24 | (2.91) | 16.20 |
Generex Biotechnology Additional Predictive Modules
Most predictive techniques to examine Generex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Generex using various technical indicators. When you analyze Generex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Generex Biotechnology Predictive Indicators
The successful prediction of Generex Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Generex Biotechnology Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Generex Biotechnology based on analysis of Generex Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Generex Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Generex Biotechnology's related companies. Story Coverage note for Generex Biotechnology
The number of cover stories for Generex Biotechnology depends on current market conditions and Generex Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Generex Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Generex Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Generex Biotechnology Short Properties
Generex Biotechnology's future price predictability will typically decrease when Generex Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Generex Biotechnology Corp often depends not only on the future outlook of the potential Generex Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Generex Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.3 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Generex Biotechnology information on this page should be used as a complementary analysis to other Generex Biotechnology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Generex OTC Stock
If you are still planning to invest in Generex Biotechnology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Generex Biotechnology's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |